Company

AuXin Surgery was incorporated in Belgium in January 2014 as a limited liability company. The Company is the pioneer of devices for chemically assisted dissection (CADISS® Method) in surgery.

The objective is to make available to surgeons this novel method for use in many surgical procedures. The Company develops and sells complete CADISS® systems for targeted applications..

AuXin Surgery is ISO 13485 (2016) certified.

Management Team

DELCORPS Xavier

CHIEF COMMERCIAL OFFICER

x

VERJANS Benoît

CHIEF EXECUTIVE OFFICER

x

FERRIERE Laurent

CHIEF TECHNOLOGY OFFICER

QA/RA DIRECTOR

 

x

GORDENNE Valérie

CHIEF SCIENTIFIC OFFICER

x

Shareholders

Gilles Capart & Family

Business Angels

Angels.be

Collaborations

Scientific

Industrial

Belgian funding

European funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 882323.

News & Events

Congresses / Expert presentation – CADISS®

All
Congresses
Seminars
Next AuXin congresses
Distributor congresses
Press
Nov
19
2021

BRUSSELS INTERNATIONAL SPINE SYMPOSIUM || MOTION MEDICAL

Next Congresses
Nov
03
2021

GLOBAL SPINE CONGRESS || FRANCE

Next Congresses
Oct
06
2021

EUROSPINE 2021 || AUSTRIA – VIENNA

Next Congresses
Mar
30
2021

Santé : des techniques innovantes || La Première || RTBF

Press
Mar
22
2021

THINK-TANK IN OTOLARYNGOLOGY – ENT innovations and pearls

Webinars
Jan
21
2021

CADISS® THE NEW DISSECTING SYSTEM FOR MIDDLE EAR SURGERY

Webinars
Déc
17
2020

CADISS SYSTEM A new solution for more selective dissection in spine & Musculoskeletal surgery

Webinars
Déc
03
2020

Healthcare Expo | Taiwan

CongressesNext Congresses
Oct
30
2020

ONLINE ID SPINE 2020 | Spine Society Belgium

Congresses
Oct
28
2020

Medlab | Bangkok

Congresses

Careers